Home » Newsletters » BioWorld Science

BioWorld Science

May 14, 2002

View Archived Issues

Orally available thrombin inhibitor designed at LG Chem

Fujisawa reveals new series of potent human Y5 receptor antagonists

U.S. researchers successfully design soft cannabinoid analogues with potential in glaucoma Rx

Extended pharmacokinetics, pharmacodynamics confirmed for Albuferon in primates

PPARalpha may play an important role in angiotensin II-induced hypertension

Preclinical data for M-100240 reported at ASH meeting

Tadalafil: a new treatment option for men with erectile dysfunction

New data on rosiglitazone reported at the ASH meeting

Dose-dependent efficacy of the renin inhibitor aliskiren confirmed in hypertensive patients

Potential efficacy of adenosine analogue in atherosclerotic and inflammatory processes

Phase III data on Cidecin in complicated skin and soft tissue infections

Wyeth announces corrections to sirolimus prescribing information

COMT inhibitors useful for Rx of Parkinson's disease described in recent patent

(S)-Amlodipine enters phase II for treatment of hypertension

NCX-4016 inhibits vascular inflammation and platelet activation in phase I/IIa study

Biosearch reacquires North American rights to topical ramoplanin

Isotechnika and Roche focus ISAtx-247 development on transplantation

Enrollment completed in phase I trial of DAC:TI in hemodialysis patients with AV shunts

Genmab and ACE BioSciences to develop antibody therapeutics for infectious diseases

FDA advisory committee hands down positive opinion on acamprosate NDA

Bryostatin 1 gains E.U. orphan drug designation in esophageal cancer

Glycine transporter inhibitors and uses thereof claimed by Gliatech

Merck KGaA patents nicotinic acetylcholine receptor agonists

Benzamidine derivatives from Genentech inhibit serine proteases involved in thrombosis

Recent patent covers new agents for melatonergic system disorders

Antagonists at integrin receptors described for bone disorders, etc.

Merck presents new series of thrombin inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...